866-997-4948(US-Canada Toll Free)

United States Therapeutic Nuclear Medicines Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 99 Pages

In this report, the United States Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Therapeutic Nuclear Medicines in these regions, from 2012 to 2022 (forecast).

United States Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Nuclear Medicines for each application, including
Hospitals
Ambulatory Surgical Centers
Other

Table of Contents

United States Therapeutic Nuclear Medicines Market Report 2017
1 Therapeutic Nuclear Medicines Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines by Product Category
1.2.1 United States Therapeutic Nuclear Medicines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Therapeutic Nuclear Medicines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Beta Emitters Therapeutic Nuclear Medicines
1.2.4 Alpha Emitters Therapeutic Nuclear Medicines
1.2.5 Brachytherapy Therapeutic Nuclear Medicines
1.3 United States Therapeutic Nuclear Medicines Market by Application/End Users
1.3.1 United States Therapeutic Nuclear Medicines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 United States Therapeutic Nuclear Medicines Market by Region
1.4.1 United States Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.3 Southwest Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.5 New England Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.6 The South Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.7 The Midwest Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022)
1.5.1 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
1.5.2 United States Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)

2 United States Therapeutic Nuclear Medicines Market Competition by Players/Suppliers
2.1 United States Therapeutic Nuclear Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Therapeutic Nuclear Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Therapeutic Nuclear Medicines Average Price by Players/Suppliers (2012-2017)
2.4 United States Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.4.1 United States Therapeutic Nuclear Medicines Market Concentration Rate
2.4.2 United States Therapeutic Nuclear Medicines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Therapeutic Nuclear Medicines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Therapeutic Nuclear Medicines Sales and Market Share by Region (2012-2017)
3.2 United States Therapeutic Nuclear Medicines Revenue and Market Share by Region (2012-2017)
3.3 United States Therapeutic Nuclear Medicines Price by Region (2012-2017)

4 United States Therapeutic Nuclear Medicines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Therapeutic Nuclear Medicines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
4.3 United States Therapeutic Nuclear Medicines Price by Type (2012-2017)
4.4 United States Therapeutic Nuclear Medicines Sales Growth Rate by Type (2012-2017)

5 United States Therapeutic Nuclear Medicines Sales (Volume) by Application (2012-2017)
5.1 United States Therapeutic Nuclear Medicines Sales and Market Share by Application (2012-2017)
5.2 United States Therapeutic Nuclear Medicines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Therapeutic Nuclear Medicines Players/Suppliers Profiles and Sales Data
6.1 Cardinal Health
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Mallkrodt Plc
6.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Mallkrodt Plc Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GE Healthcare
6.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Lantheus Medical Imaging
6.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bayer AG
6.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bracco Imaging SpA
6.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bracco Imaging SpA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Eczacibasi-Monrol Nuclear Products
6.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Nordion
6.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Advanced Accelerator Applications SA
6.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 IBA Molecular Imaging
6.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
7.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Therapeutic Nuclear Medicines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Therapeutic Nuclear Medicines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Therapeutic Nuclear Medicines Sales Volume Forecast by Type (2017-2022)
11.3 United States Therapeutic Nuclear Medicines Sales Volume Forecast by Application (2017-2022)
11.4 United States Therapeutic Nuclear Medicines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Therapeutic Nuclear Medicines
Figure United States Therapeutic Nuclear Medicines Market Size (MT) by Type (2012-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture
Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture
Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture
Figure United States Therapeutic Nuclear Medicines Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Other Examples
Figure United States Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2012-2022)
Figure The West Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2022)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure 2017 United States Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure United States Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers
Figure 2017 United States Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers
Table United States Market Therapeutic Nuclear Medicines Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Therapeutic Nuclear Medicines Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Therapeutic Nuclear Medicines Market Share of Top 3 Players/Suppliers
Figure United States Therapeutic Nuclear Medicines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Therapeutic Nuclear Medicines Product Category
Table United States Therapeutic Nuclear Medicines Sales (MT) by Region (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Region in 2016
Table United States Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Revenue Market Share by Region (2012-2017)
Figure United States Therapeutic Nuclear Medicines Revenue Market Share by Region in 2016
Table United States Therapeutic Nuclear Medicines Price (USD/MT) by Region (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Type in 2016
Table United States Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2016
Table United States Therapeutic Nuclear Medicines Price (USD/MT) by Types (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Growth Rate by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Market Share by Application in 2016
Table United States Therapeutic Nuclear Medicines Sales Growth Rate by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Growth Rate by Application (2012-2017)
Table Cardinal Health Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Mallkrodt Plc Basic Information List
Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Lantheus Medical Imaging Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Bracco Imaging SpA Basic Information List
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Nordion Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Advanced Accelerator Applications SA Basic Information List
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table IBA Molecular Imaging Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in United States (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Players/Suppliers in 2016
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Nuclear Medicines Price (USD/MT) Trend Forecast (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Type in 2022
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Application in 2022
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Nuclear Medicines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *